⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Innovent's Partner Ollin Biosciences Announces Final Data from Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo) in Wet Age-Related Macular Degeneration and Diabetic Macular Edema
prnewswire.com
REGN
CIO 100 Awards & Conference Announces 2026 CIO 100 Honorees, Recognizing Enterprise-Scale Technology Leadership
accessnewswire.com
HPE
IBM
AVNT
AX
BAC
MSFT
BRK.A
JNJ
MRK
AMZN
GOOG
QCOM
T
VZ
MU
INTC
AMD
NVDA
CRM
ADBE
CSCO
ORCL
SAP
ACN
MS
AXP
MA
V
UNM
ALL
CB
TRV
GE
HON
MMM
DOW
DD
EL
KHC
PEP
KO
MCD
SBUX
CMG
YUM
DG
WMT
TGT
HD
LOW
COST
UPS
FDX
XPO
JBHT
CNC
CI
ELV
HCA
CVS
UNP
NSC
BNTX
MRNA
GILD
AMGN
REGN
ABBV
BMY
PFE
LLY
SNY
AZN
ELAN
MSCI
FICO
EXPD
BKNG
MAR
H
WYNN
LVS
MGM
CCL
RCL
NCLH
LULU
UA
NKE
RL
PVH
TJX
BBY
MDT
ISRG
ABT
BA
LMT
RTX
GD
CAT
DE
CNH
OSK
J
CBRE
JLL
SPG
PLD
AMT
EQIX
CCI
AVTR
BIIB
ALGN
EXPE
AEP
NEE
SO
DUK
PCG
SRE
WEC
ED
D
ETR
NI
PNW
EXC
EIX
FE
CMS
LNT
ZION
KEY
PNC
USB
WFC
JPM
GS
SCHW
SPGI
AMAT
AVGO
NXPI
ADI
TXN
MRVL
SNPS
CDNS
MCHP
ON
INFY
WDC
SE
BABA
JD
PDD
MELI
ETSY
EBAY
SHOP
PYPL
COIN
HOOD
UPST
SOFI
AFRM
PLTR
SNOW
DDOG
PANW
CRWD
ZS
FTNT
CHKP
CYBR
TENB
NTAP
STX
APP
MOVE
ACCL
AES
ALB
APLS
ASML
BKR
BROS
BWA
CHTR
EOG
EXAS
F
FCX
KMB
L
LBRDK
LUV
MAS
META
MNST
MO
MTRX
NOC
O
OC
ODFL
OTIS
OXM
PAYX
PHI
PPC
PRGO
PSX
RF
ROST
ROKU
RS
S
SEE
SIRI
TCOM
THC
THG
THS
TIGR
TMO
TMUS
TOL
TOP
TRIP
TRMB
TRN
TSLA
TTWO
TXRH
UDR
ULTA
UNFI
UNH
VRSK
VRTX
VTR
W
WHR
WMB
WST
WY
XOM
XRAY
XYL
YMM
Z
ZBH
ZBRA
ZTO
ZTS
Ollin Biosciences Announces Final Data From Randomized Head-to-Head Study of OLN324 Compared to Faricimab (Vabysmo®) in Wet Age-Related Macular Degeneration and Diabetic Macular Edema
businesswire.com
REGN
Институт Critical Path Institute запускает программу One to Millions, чтобы изменить будущее персонализированной медицины в глобальном масштабе USA - Pусский USA - English USA - English USA - Français USA - slovenčina USA - Polski USA - español USA -
prnewswire.com
BMY
MRK
PFE
GILD
REGN
AZN
NVS
BIIB
ALKS
CRIS
EDIT
NTLA
Bispecific T-Cell Engagers Market Insights Report (2026-2030) Featuring Strategic Analysis of Pfizer, Johnson & Johnson, Roche, AbbVie, Sanofi and Other Key Players
globenewswire.com
PFE
JNJ
AMGN
ABBV
SNY
REGN
MRK
Pruritus Therapeutics Market Size is Projected to Reach USD 15.58 Billion by 2035 Due to the Increasing Cases of Chronic Inflammatory Skin Diseases Globally | SNS Insider
globenewswire.com
REGN
LULU
Inveniam Hires Former Bloomberg and Moody's Leader to Meet Rising Institutional Demand for AI-Ready Data
prnewswire.com
IBM
MUFG
MS
GS
JPM
BAC
WFC
SCHW
AMTD
AXP
V
MA
PYPL
COF
SYK
BMY
PFE
MRK
JNJ
UNH
CVS
CI
AMGN
GILD
BIIB
REGN
AZN
NVS
TSM
NVDA
INTC
AMD
QCOM
AMAT
LRCX
MU
ADBE
CRM
GOOG
GOOGL
AMZN
MSFT
AAPL
META
NFLX
CMCSA
T
VZ
DIS
HD
MCD
SBUX
KO
PEP
CAT
BA
GE
XOM
CVX
HSBC
BCS
NYT
BKR
HAL
SLB
COP
EOG
APA
OXY
DVN
Regeneron to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2026
globenewswire.com
REGN
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid
globenewswire.com
REGN
SNY
Dupixent® (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)
globenewswire.com
SNY
REGN